- Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children
- Long‐acting beta2‐agonists for bronchiectasis
- Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid
- Long-acting beta2-agonists for chronic obstructive pulmonary disease
- Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease
- Long‐acting beta2‐agonists versus theophylline for maintenance treatment of asthma
- Low level laser therapy for treating tuberculosis
- Lung lavage for meconium aspiration syndrome in newborn infants
- Lung protective ventilation strategy for the acute respiratory distress syndrome
- Lung volume reduction surgery for diffuse emphysema
- Macrolide antibiotics for cystic fibrosis
- Macrolides for diffuse panbronchiolitis
- Macrolides versus placebo for chronic asthma
- Magnesium sulfate for persistent pulmonary hypertension of the newborn
- Magnesium sulfate for treating exacerbations of acute asthma in the emergency department
- Manual therapy for asthma
- Mast‐cell stabilising agents to prevent exercise‐induced bronchoconstriction
- Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child
- Mechanical insufflation-exsufflation for people with neuromuscular disorders
- Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.
